2m 2m 2m 2m 2m 2m 2m
GINKGO BIO-A (DNA)
NYSE
$9.76-$0.25 (-2.55%)
Price as of Oct 22, 2026 7:47 PM EDT- $554.4MMarket Cap
- -21.67%1-Year Change
- BiotechnologyIndustry
GINKGO BIO-A (DNA)
$9.76-$0.25 (-2.55%)
DNA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $10.01 | ||
Change | +$0.15 (+1.52%) | ||
Open | $9.88 | ||
High | $10.10 | ||
Low | $9.61 | ||
Previous Close | $9.86 | ||
Volume | 1,777,200 | ||
30-Day Average Volume | 3,627,553 | ||
1-Week Change | -13.18% | ||
1-Month Change | 25.44% | ||
1-Year Change | -21.67% | ||
3-Year Change | -84.06% | ||
5-Year Change | -98.11% | ||
Fundamentals | |||
Shares Outstanding | 55.4M | ||
Total Assets | $990.0M | ||
Market Cap | $554.4M | ||
Enterprise Value | $469.9M | ||
Period: QTR TTM FY | |||
Revenue | $20.2M | ||
Net Income | -$46.7M | ||
Free Cash Flow | -$46.9M | ||
EBIT | -$46.6M | ||
EBITDA | -$34.3M | ||
Net Working Capital | $259.8M | ||
EPS | -$0.75 | ||
Enterprise Value/EBITDA | -14 | ||
Enterprise Value/Revenue | 23 | ||
P/B | 1 | ||
P/E | -13 | ||
PEG | -0 | ||
Price/Free Cash Flow | -12 | ||
Price/Operating Cash Flow | -13 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 40 | ||
Last Split Date | 08/20/2024 | ||
Earnings & Revenue